z-logo
open-access-imgOpen Access
Continuous intravenous flumazenil infusion in a patient with chlordiazepoxide toxicity and hepatic encephalopathy
Author(s) -
Moh’d Al-Halawani,
Parijat Sen,
Yazan Abdeen,
Hamid Shaaban,
Alan Klukowicz,
Richard A. Miller
Publication year - 2015
Publication title -
journal of emergencies, trauma and shock
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.313
H-Index - 29
eISSN - 0974-519X
pISSN - 0974-2700
DOI - 10.4103/0974-2700.145422
Subject(s) - flumazenil , benzodiazepine , chlordiazepoxide , medicine , hepatic encephalopathy , anesthesia , hemoperfusion , encephalopathy , diazepam , cirrhosis , receptor , hemodialysis
Flumazenil, a benzodiazepine receptor antagonist, is the drug of choice for the diagnosis and treatment of benzodiazepine overdose. We are presenting a patient with chronic alcoholism and alcoholic liver disease, who came with alcohol withdrawal symptoms and treated chlordiazepoxide. Subsequently he developed a prolonged change in mental status that required treatment for benzodiazepine overdose and hepatic encephalopathy with flumazenil infusion for 28 days.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here